Evaluation of Clinical Outcomes After Revascularization in Patients With Chronic Limb-Threatening Ischemia: Results From a Prospective National Cohort Study (RIVALUTANDO).


Journal

Angiology
ISSN: 1940-1574
Titre abrégé: Angiology
Pays: United States
ID NLM: 0203706

Informations de publication

Date de publication:
05 2021
Historique:
pubmed: 8 1 2021
medline: 11 5 2021
entrez: 7 1 2021
Statut: ppublish

Résumé

We evaluated the outcomes of revascularization in patients with chronic limb-threatening ischemia (CLTI) treated in real-world settings. This is a prospective multicenter cohort study with 12-month follow-up enrolling patients (n = 287) with CLTI undergoing open, endovascular, or hybrid lower extremity revascularization. The primary end point was amputation-free survival (AFS) at 12 months. Cox proportional analysis was used to determine independent predictors of amputation and restenosis. At 30 days, major adverse cardiovascular and major adverse limb events (MALE) rates were 3.1% and 2.1%, respectively. At 1 year, the overall survival rate was 88.8%, the AFS was 86.6%, and the primary patency was 70.5%. Freedom from MALE was 62.5%. After multivariate analysis, smoking (hazard ratio [HR] = 2.2,

Identifiants

pubmed: 33406850
doi: 10.1177/0003319720980619
doi:

Substances chimiques

Cardiovascular Agents 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

480-489

Investigateurs

Angiletta G (A)
Rivellini C (R)
Pane B (P)
Spinella G (S)
Pipitò N (P)
Spinelli D (S)
Derone G (D)
Kahlberg A (K)
Carta N (C)
Lauricella A (L)
Maresca L (M)
Antonello M (A)
Piazza M (P)
Bonvini S (B)
Wassermann V (W)
Trani A (T)
Barresi A (B)
Di Citra G (DC)
Spinelli F (S)
Montelione N (M)
Paroni G (P)
Magistro G (M)
Ceriello D (C)
Merlo M (M)
Giordano F (G)
Ruzzi U (R)
Mazzitelli G (M)
Mele M (M)
Giannace G (G)
Alba G (A)
Grottola G (G)
Pazzaglia M (P)
Giubbolini G (G)
Baldi B (B)
Guerrieri W (G)
Benevento D (B)
Cappelli A (C)

Auteurs

Gianmarco de Donato (G)

Vascular Surgery, 9313University of Siena, Italy.

Filippo Benedetto (F)

Vascular Surgery, 18980University of Messina, Italy.

Francesco Stilo (F)

Vascular Surgery, University of Rome Campus Biomedico, Italy.

Roberto Chiesa (R)

Vascular Surgery, University of Milano San Rafael, Italy.

Domenico Palombo (D)

Vascular Surgery, 9302University of Genova, Italy.

Edoardo Pasqui (E)

Vascular Surgery, 9313University of Siena, Italy.

Claudia Panzano (C)

Vascular Surgery, 9313University of Siena, Italy.

Raffaele Pulli (R)

Vascular Surgery, 9295University of Bari, Italy.

Claudio Novali (C)

Vascular Surgery, Hospital of Cuneo, Italy.

Roberto Silingardi (R)

Vascular Surgery, 9306University of Modena, Italy.

Francesco Grego (F)

Vascular Surgery, 9308University of Padova, Italy.

Giancarlo Palasciano (G)

Vascular Surgery, 9313University of Siena, Italy.

Carlo Setacci (C)

Vascular Surgery, 9313University of Siena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH